Status: Not yet recruiting
Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers
This is an open, two-part study in healthy male volunteers, aged 30-65 years. This trial aims to understand how the human body absorbs, distributes, metabolizes and eliminates ontunisertib after a single oral dose of radiolabelled test medicine (\[14C\]ontunisertib) and determine the routes and rates of elimination of the test medicine.
Participants needed: 8
Trial details
Phase: Phase 1Age: 30-65Biological sex: MaleType: InterventionalSponsor: Agomab Spain S.L.U.Updated: Jun 29, 2026Locations: 1
Eligibility criteria
Males aged 30 to 65 years inclusive at the time of signing informed consent [+3]
Serious adverse reaction or serious hypersensitivity to any drug or formulation... [+6]